New findings reinforce the importance of maternal vaccination and boosting during pregnancy.

Wednesday, February 14, 2024 COVID-19 Vaccination and Boosting During Pregnancy Protects Infants for Six Months Caption: Transmission electron micrograph of SARS-CoV-2 virus particles (gold) within endosomes of a heavily infected nasal Olfactory Epithelial Cell. Credit: NIAID A NIAID-funded study recently found that when pregnant women receive an mRNA COVID-19 vaccine, the antibodies induced by the vaccine can cross the placenta, providing the newborn with a defense against COVID-19 from the day of birth. However, researchers were still unsure how long that protection would last. A continuation of that study has found that the infants still had protection from COVID-19 infection for at least six months after birth. In addition, when the pregnant volunteers also received a COVID-19 booster during pregnancy, their infants had much higher levels of antibodies during the first six months, and had greater protection from COVID-19 infection. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107